Skip to Main Content

Paper Details

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Nat Biotechnol
497
2018
Author NameAffiliation
Ronald C HendricksonMemorial Sloan Kettering Cancer Center
Ronald C HendricksonMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2